Page 35 - Read Online

Padoan et al. Vessel Plus 2021;5:41 https://dx.doi.org/10.20517/2574-1209.2021.41 Page 17 of 18

69. Masuda T, Izumi Y, Takeshita H, et al. Granulomatosis with polyangiitis presenting as a choroidal tumor. Case Rep Rheumatol
2015;2015:271823. DOI PubMed PMC
70. Spanuchart I, Zungsontiporn N, O-charoen P, et al. Granulomatosis with polyangiitis: a case of nasal mass, necrotic lung, and normal
kidneys. Hawaii J Med Public Health 2015;74:27-9. PubMed PMC
71. Coates ML, Martinez Del Pero M. Updates in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis for the ENT
surgeon. Clin Otolaryngol 2020;45:316-26. DOI PubMed
72. Greco A, Marinelli C, Fusconi M, et al. Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol
2016;29:151-9. DOI PubMed PMC
73. Pendolino AL, Unadkat S, Zhang H, et al. The role of surgery in antineutrophil cytoplasmic antibody-associated vasculitides affecting
the nose and sinuses: a systematic review. SAGE Open Med 2020;8:205031212093673. DOI PubMed PMC
74. Devaney KO, Travis WD, Hoffman G, et al. Interpretation of head and neck biopsies in Wegener’s granulomatosis. a pathologic
study of 126 biopsies in 70 patients. Am J Surg Pathol 1990;14:555-64. DOI PubMed
75. Seccia V, Baldini C, Latorre M, et al. Focus on the involvement of the nose and paranasal sinuses in Eosinophilic Granulomatosis
with polyangiitis (Churg-Strauss Syndrome): nasal cytology reveals infiltration of eosinophils as a very common feature. Int Arch
Allergy Immunol 2018;175:61-9. DOI PubMed
76. Vega Villanueva KL, Espinoza LR. Eosinophilic vasculitis. Curr Rheumatol Rep 2020;22:5. DOI PubMed
77. D’Anza B, Langford CA, Sindwani R. Sinonasal imaging findings in Granulomatosis with polyangiitis (Wegener granulomatosis): a
systematic review. Am J Rhinol Allergy 2017;31:16-21. DOI PubMed
78. Pagnoux C. Updates in ANCA-associated vasculitis. Eur J Rheumatol 2016;3:122-33. DOI PubMed PMC
79. Carnevale C, Arancibia-Tagle D, Sarría-Echegaray P, et al. Head and neck manifestations of granulomatosis with polyangiitis: a
retrospective analysis of 19 patients and review of the literature. Int Arch Otorhinolaryngol 2019;23:165-71. DOI PubMed PMC
80. Hernández-Rodríguez J, Hoffman GS, Koening CL. Surgical interventions and local therapy for Wegener’s granulomatosis. Curr
Opin Rheumatol 2010;22:29-36. DOI PubMed
81. Erickson VR, Hwang PH. Wegener’s granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head
Neck Surg 2007;15:170-6. DOI PubMed
82. Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
Ann Rheum Dis 2016;75:1583-94. DOI PubMed
83. De Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in
early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:2461-9. DOI PubMed
84. Puéchal X. Granulomatosis with polyangiitis (Wegener’s). Joint Bone Spine 2020;87:572-8. DOI PubMed
85. Stegeman CA, Cohen Tervaert JW, De Jong PE, et al. Trimethoprim-sulfamethoxazole (Co-Trimoxazole) for the prevention of
relapses of Wegener’s granulomatosis. N Engl J Med 1996;335:16-20. DOI PubMed
86. Padoan R, Felicetti M, Gatto M, et al. Rituximab-associated hypogammaglobulinaemia in ANCA-associated vasculitis and
connective tissue diseases: a longitudinal observational study. Clin Exp Rheumatol 2020;38:188-94. PubMed
87. Raffray L, Guillevin L. Rituximab treatment of ANCA-associated vasculitis. Expert Opin Biol Ther 2020;20:899-910. DOI PubMed
88. Okada M, Suemori K, Takagi D, et al. The treatment outcomes of rituximab for intractable otitis media with ANCA-associated
vasculitis. Auris Nasus Larynx 2019;46:38-42. DOI PubMed
89. Durel C-A, Hot A, Trefond L, et al. Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and
histological presentation, therapeutic management, and outcome from 59 patients. Rheumatology (Oxford) 2019;58:1565-73. DOI
PubMed
90. Holle JU, Dubrau C, Herlyn K, et al. Rituximab for refractory granulomatosis with polyangiitis (Wegener’s granulomatosis):
comparison of efficacy in granulomatous versus vasculitic manifestations. Ann Rheum Dis 2012;71:327-33. DOI PubMed
91. Aries PM, Hellmich B, Voswinkel J, et al. Lack of efficacy of rituximab in Wegener’s granulomatosis with refractory granulomatous
manifestations. Ann Rheum Dis 2006;65:853-8. DOI PubMed PMC
92. Seo P, Specks U, Keogh KA. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous
manifestations. J Rheumatol 2008;35:2017-23. PubMed
93. Pullerits R, Ljevak M, Vikgren J, et al. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of Antineutrophil
Cytoplasmic Antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre. Scand J Immunol 2012;76:411-20.
DOI PubMed
94. Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med
2017;376:1921-32. DOI PubMed PMC
95. Ribi C, Cohen P, Pagnoux C, et al. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective,
randomized, open-label study of seventy-two patients. Arthritis Rheum 2008;58:586-94. DOI PubMed
96. Pagnoux C, Groh M. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-
Strauss syndrome). Expert Rev Clin Immunol 2016;12:1059-67. DOI PubMed
97. Cohen P, Pagnoux C, Mahr A, et al. Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing
glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Care Res 2007;57:686-93. DOI PubMed
98. Nagase H, Ueki S, Fujieda S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: asthma, eosinophilic granulomatosis
with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol Int 2020;69:178-86. DOI PubMed
99. Canzian A, Venhoff N, Urban ML, et al. Use of biologics to treat relapsing and/or refractory eosinophilic granulomatosis with
polyangiitis: data from a European collaborative study. Arthritis Rheumatol 2020;73:498-503. DOI PubMed